This topic contains a solution. Click here to go to the answer

Author Question: In the early 1990s, Barlow and others developed a cognitive-behavioral treatment for generalized ... (Read 76 times)

j.rubin

  • Hero Member
  • *****
  • Posts: 557
In the early 1990s, Barlow and others developed a cognitive-behavioral treatment for generalized anxiety disorder (GAD) that helps the patient
 
  a. avoid feelings of anxiety as well as the negative images associated with those feelings.
  b. confront anxiety-provoking thoughts and images.
 c. adjust medication levels as needed to cope with the anxiety.
 d. analyze the unconscious sources of the anxiety.

Question 2

Which physiological measure consistently distinguishes individuals with generalized anxiety disorder (GAD) from nonanxious normal subjects?
 
  a. Increased muscle tension
 b. Increased heart rate
 c. Decreased EEG beta activity
 d. Decreased skin conductance levels



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Kjones0604

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

b

Answer to Question 2

a




j.rubin

  • Member
  • Posts: 557
Reply 2 on: Jun 22, 2018
:D TYSM


scikid

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

For a complete list of videos, visit our video library